Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies

Macron to unveil 2.1 billion eur Novo Nordisk pharma investment in France

Medical device makers rise on relief after Wegovy obesity trial data

Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss

Wegovy's heart benefits due to more than weight loss, Novo says

Drugmaker Novo Nordisk seeks obesity, diabetes 'bolt-on' deals

Weight-loss drug maker Novo Nordisk invests $6 billion to boost output

Novo Nordisk flags continued restrictions on Wegovy supplies

Novo Nordisk in $1.3 billion deal to buy hypertension drug

Novo Nordisk's Wegovy bonanza looms large in Denmark

U.S. FDA found lapses at Novo's main U.S. factory in May 2022 -report

The maker of Wegovy and Ozempic is now Europe's most valuable company